Journal UMinho Science https://revistas.uminho.pt/index.php/jus <p><em>Journal UMinho Science</em> (JUS) is a scientific journal of the University of Minho, run by undergraduate, master, and doctoral students of the School of Sciences, with a continuous publication and digital format.</p> <p>JUS' main goal is to publish original scientific articles, contributing to the dissemination of scientific research done at the University of Minho and other national and international institutions. The areas of biology, chemistry, physics, mathematics, and earth sciences are covered, as well as any other scientific and technological areas.</p> <div>JUS provides a forum for the dissemination and discussion of news and science-related issues.</div> en-US <p><span style="font-weight: 400;">Journal Uminho Science (JUS) magazine, in order to protect the interests of the authors of the articles and also their own, follows the terms and conditions of <a href="https://creativecommons.org/licenses/by/4.0/legalcode">"Creative Commons Atribution 4.0 International Public License"</a> whose credit belongs to “Creative Commons” (<a href="https://creativecommons.org/">creativecommons.org</a>).<br /><br />By agreeing to the terms of this license you are granting us your permission to use your item under the terms and conditions specified in this license.</span></p> <p><br /><br /></p> <p><span style="font-weight: 400;">"By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.</span></p> <p> </p> <p> </p> <p><strong>Section 1 – Definitions.</strong></p> <p> </p> <p> </p> <p><span style="font-weight: 400;">Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.</span></p> <p> </p> <p><span style="font-weight: 400;">Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.</span></p> <p> </p> <p><span style="font-weight: 400;">Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section </span><a href="https://creativecommons.org/licenses/by/4.0/legalcode#s2b"><span style="font-weight: 400;">2(b)(1)-(2)</span></a><span style="font-weight: 400;"> are not Copyright and Similar Rights.</span></p> <p> </p> <p><span style="font-weight: 400;">Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.</span></p> <p> </p> <p><span style="font-weight: 400;">Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.</span></p> <p> </p> <p><span style="font-weight: 400;">Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.</span></p> <p> </p> <p><span style="font-weight: 400;">Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.</span></p> <p> </p> <p><span style="font-weight: 400;">Licensor means the individual(s) or entity(ies) granting rights under this Public License.</span></p> <p> </p> <p><span style="font-weight: 400;">Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.</span></p> <p> </p> <p><span style="font-weight: 400;">Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.</span></p> <p> </p> <p><span style="font-weight: 400;">You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.</span></p> <p> </p> <p> </p> <p><strong>Section 2 – Scope.</strong></p> <p> </p> <p> </p> <p><span style="font-weight: 400;">License grant.</span></p> <p><span style="font-weight: 400;">Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:</span></p> <ul> <li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Reproduce and Share the Licensed Material, in whole or in part; and</span></li> <li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Produce, reproduce, and Share Adapted Material.</span></li> </ul> <p><span style="font-weight: 400;">Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.</span></p> <p> </p> <p><span style="font-weight: 400;">Term. The term of this Public License is specified in Section </span><a href="https://creativecommons.org/licenses/by/4.0/legalcode#s6a"><span style="font-weight: 400;">6(a)</span></a><span style="font-weight: 400;">.</span></p> <p> </p> <p><span style="font-weight: 400;">Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section </span><a href="https://creativecommons.org/licenses/by/4.0/legalcode#s2a4"><span style="font-weight: 400;">2(a)(4)</span></a><span style="font-weight: 400;"> never produces Adapted Material.</span></p> <p> </p> <p><span style="font-weight: 400;">Downstream recipients.</span></p> <p><span style="font-weight: 400;">Offer from the Licensor – Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.</span></p> <p> </p> <p><span style="font-weight: 400;">No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.</span></p> <p> </p> <p><span style="font-weight: 400;">No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section </span><a href="https://creativecommons.org/licenses/by/4.0/legalcode#s3a1Ai"><span style="font-weight: 400;">3(a)(1)(A)(i)</span></a><span style="font-weight: 400;">.</span></p> <p> </p> <p><span style="font-weight: 400;">Other rights.</span></p> <p><span style="font-weight: 400;">Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.</span></p> <p> </p> <p><span style="font-weight: 400;">Patent and trademark rights are not licensed under this Public License.</span></p> <p> </p> <p><span style="font-weight: 400;">To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties.</span></p> <p> </p> <p> </p> <p><strong>Section 3 – License Conditions.</strong></p> <p> </p> <p><span style="font-weight: 400;">Your exercise of the Licensed Rights is expressly made subject to the following conditions.</span></p> <p> </p> <p><span style="font-weight: 400;">Attribution.</span></p> <p><span style="font-weight: 400;">If You Share the Licensed Material (including in modified form), You must retain the following if it is supplied by the Licensor with the Licensed Material:</span></p> <ul> <li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);</span></li> <li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">A copyright notice;</span></li> <li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">A notice that refers to this Public License;</span></li> <li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">A notice that refers to the disclaimer of warranties;</span></li> <li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">A URI or hyperlink to the Licensed Material to the extent reasonably practicable;</span></li> <li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Indicate if You modified the Licensed Material and retain an indication of any previous modifications; and</span></li> <li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.</span></li> </ul> <p> </p> <p><span style="font-weight: 400;">You may satisfy the conditions in Section </span><a href="https://creativecommons.org/licenses/by/4.0/legalcode#s3a1"><span style="font-weight: 400;">3(a)(1)</span></a><span style="font-weight: 400;"> in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.</span></p> <p> </p> <p><span style="font-weight: 400;">If requested by the Licensor, You must remove any of the information required by Section </span><a href="https://creativecommons.org/licenses/by/4.0/legalcode#s3a1A"><span style="font-weight: 400;">3(a)(1)(A)</span></a><span style="font-weight: 400;"> to the extent reasonably practicable.</span></p> <p> </p> <p><span style="font-weight: 400;">If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.</span></p> <p> </p> <p> </p> <p><strong>Section 4 – Sui Generis Database Rights.</strong></p> <p> </p> <p> </p> <p><span style="font-weight: 400;">Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:</span></p> <ul> <li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">For the avoidance of doubt, Section </span><a href="https://creativecommons.org/licenses/by/4.0/legalcode#s2a1"><span style="font-weight: 400;">2(a)(1)</span></a><span style="font-weight: 400;"> grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database;</span></li> <li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">If You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; </span></li> <li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">You must comply with the conditions in Section </span><a href="https://creativecommons.org/licenses/by/4.0/legalcode#s3a"><span style="font-weight: 400;">3(a)</span></a><span style="font-weight: 400;"> if You Share all or a substantial portion of the contents of the database.</span></li> </ul> <p> </p> <p><span style="font-weight: 400;">For the avoidance of doubt, this Section </span><a href="https://creativecommons.org/licenses/by/4.0/legalcode#s4"><span style="font-weight: 400;">4</span></a><span style="font-weight: 400;"> supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.</span></p> <p> </p> <p> </p> <p><strong>Section 5 – Disclaimer of Warranties and Limitation of Liability.</strong></p> <p> </p> <p> </p> <p><span style="font-weight: 400;">Unless otherwise separately undertaken by the Licensor, to the extent possible, the Licensor offers the Licensed Material as-is and as-available, and makes no representations or warranties of any kind concerning the Licensed Material, whether express, implied, statutory, or other. This includes, without limitation, warranties of title, merchantability, fitness for a particular purpose, non-infringement, absence of latent or other defects, accuracy, or the presence or absence of errors, whether or not known or discoverable. Where disclaimers of warranties are not allowed in full or in part, this disclaimer may not apply to You.</span></p> <p> </p> <p><span style="font-weight: 400;">To the extent possible, in no event will the Licensor be liable to You on any legal theory (including, without limitation, negligence) or otherwise for any direct, special, indirect, incidental, consequential, punitive, exemplary, or other losses, costs, expenses, or damages arising out of this Public License or use of the Licensed Material, even if the Licensor has been advised of the possibility of such losses, costs, expenses, or damages. Where a limitation of liability is not allowed in full or in part, this limitation may not apply to You.</span></p> <p> </p> <p><span style="font-weight: 400;">The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.</span></p> <p> </p> <p><strong>Section 6 – Term and Termination.</strong></p> <p> </p> <p><span style="font-weight: 400;">This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.</span></p> <p> </p> <p><span style="font-weight: 400;">Where Your right to use the Licensed Material has terminated under Section </span><a href="https://creativecommons.org/licenses/by/4.0/legalcode#s6a"><span style="font-weight: 400;">6(a)</span></a><span style="font-weight: 400;">, it reinstates:</span></p> <ul> <li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; </span></li> <li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Or, upon express reinstatement by the Licensor.</span></li> </ul> <p> </p> <p><span style="font-weight: 400;">For the avoidance of doubt, this Section </span><a href="https://creativecommons.org/licenses/by/4.0/legalcode#s6b"><span style="font-weight: 400;">6(b)</span></a><span style="font-weight: 400;"> does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.</span></p> <p> </p> <p><span style="font-weight: 400;">For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.</span></p> <p> </p> <p><span style="font-weight: 400;">Sections </span><a href="https://creativecommons.org/licenses/by/4.0/legalcode#s1"><span style="font-weight: 400;">1</span></a><span style="font-weight: 400;">, </span><a href="https://creativecommons.org/licenses/by/4.0/legalcode#s5"><span style="font-weight: 400;">5</span></a><span style="font-weight: 400;">, </span><a href="https://creativecommons.org/licenses/by/4.0/legalcode#s6"><span style="font-weight: 400;">6</span></a><span style="font-weight: 400;">, </span><a href="https://creativecommons.org/licenses/by/4.0/legalcode#s7"><span style="font-weight: 400;">7</span></a><span style="font-weight: 400;">, and </span><a href="https://creativecommons.org/licenses/by/4.0/legalcode#s8"><span style="font-weight: 400;">8</span></a><span style="font-weight: 400;"> survive termination of this Public License.</span></p> <p> </p> <p><strong>Section 7 – Other Terms and Conditions.</strong></p> <p> </p> <p><span style="font-weight: 400;">The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.</span></p> <p> </p> <p><span style="font-weight: 400;">Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.</span></p> <p> </p> <p><strong>Section 8 – Interpretation.</strong></p> <p> </p> <p><span style="font-weight: 400;">For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.</span></p> <p> </p> <p><span style="font-weight: 400;">To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.</span></p> <p> </p> <p><span style="font-weight: 400;">No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.</span></p> <p> </p> <p><span style="font-weight: 400;">Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority."</span></p> <p> </p> jus@ecum.uminho.pt (Journal UMinho Science) jus@ecum.uminho.pt (Journal UMinho Science) Wed, 20 Mar 2024 15:51:42 +0000 OJS 3.3.0.10 http://blogs.law.harvard.edu/tech/rss 60 Exposure to cobalt metal (without tungsten carbide) and some cobalt compounds: a literature review https://revistas.uminho.pt/index.php/jus/article/view/5230 <p>Cobalt is a natural metallic element with extensive applications across multiple industries, and a critical metal for lithium-ion battery production. Cobalt's only known biological function is its role as a metal component of vitamin B12. Other cobalt compounds have been described as toxic to the environment and the human body following excessive exposure. The International Agency for Research on Cancer (IARC) has classified cobalt, including cobalt metal and soluble cobalt(II) salts, as Group 2A, meaning it is probably carcinogenic to humans. This review aims to present a comprehensive overview of historical and current sources of cobalt in diverse exposure settings, along with its various intake routes. An extensive literature search was conducted between September 2021 and January 2022, analysing over 300 publications. The primary goal of these studies was to identify cobalt sources, intake routes, and exposure pathways. Workers may be exposed to various cobalt compounds and metal powders primarily through inhalation, but exposure can also occur via skin contact or ingestion. For the general population, food typically arises as the predominant source of cobalt exposure. Furthermore, exposure may occur through ambient air, tobacco smoke, and medical implants.</p> Amélia Paula Marinho Reis Copyright (c) 2024 Amélia Paula Marinho Reis https://creativecommons.org/licenses/by/4.0 https://revistas.uminho.pt/index.php/jus/article/view/5230 Wed, 20 Mar 2024 00:00:00 +0000 Studying Floristic Composition for the Conservation of Parque das Camélias (Braga Municipality) Biodiversity https://revistas.uminho.pt/index.php/jus/article/view/5383 <p>The conservation of biodiversity and the understanding of its distribution patterns play a crucial role in promoting effective land management. The present study aimed to identify herbaceous species in <em>Parque Urbano das Camélias</em> located in the city of Braga. The research was conducted as part of an ongoing collaboration between the School of Sciences at the University of Minho and the Municipal Council of Braga. The site was sampled using the quadrant method, employing a 1m<sup>2</sup> measurement, to encompass 12 strategically selected locations throughout the park. The findings encompassed 28 distinct specimens, with identification achieved at the genus level for 27 and at the species level for 25. The study area harbors both native species from mainland Portugal and exotic species, with the Poaceae family being predominant, accounting for 50% of the identified individuals. Some of the species identified in the park include <em>Avena</em> spp., <em>Bromus madritensis</em>, and <em>Plantago lanceolata</em>. The study discusses preservation strategies and biodiversity enhancement for the <em>Parque Urbano das Camélias</em>.</p> Barbara Lages, Ana Castro, Renato Henriques, António Teixeira, Hernâni Gerós Copyright (c) 2024 Barbara Lages, Ana Castro, Renato Henriques, António Teixeira, Hernâni Gerós https://creativecommons.org/licenses/by/4.0 https://revistas.uminho.pt/index.php/jus/article/view/5383 Mon, 25 Mar 2024 00:00:00 +0000 Cellular uptake, biodistribution and protection against oxidative damage by Withania somnifera leaf extract-loaded PCL and MPEG-PCL nanoparticles https://revistas.uminho.pt/index.php/jus/article/view/5628 <p><em>Withania somnifera</em> (WS) or Ashwagandha is a well-known medicinal plant, cultivated in dry areas of India and Pakistan, where it represents an important resource as a widely used medicinal crop. Because of its anti-inflammatory and immunomodulatory effects, its extract is used, alone or in combination with other herbal extracts, in the treatment of age-related and neurodegenerative disorders. For tapping on the important therapeutic potential of this resource for biomedicine, strategies for controlled delivery and biodistribution improvement are necessary to guarantee treatment efficacy. Pharmacological properties of WS leaf extract (WSE) are mainly attributed to the presence of withanolides. In the present study, WSE was encapsulated in nanoparticles composed of biodegradable polymers as poly-ε-caprolactone (PCL) and methoxy poly-ethylene glycol poly-ε-caprolactone (MPEG-PCL) di-block copolymer. Laser doppler anemometry (LDA), X-Ray Diffraction (XRD) and Transmission Electron Microscopy (TEM) were used to analyze their size and shape. The particle size distribution of WSE-loaded PCL and MPEG-PCL nanoparticles was measured as 214-268 and 30-62 nm, respectively, presenting in both cases a spherical shape. U251 glioma cells, representative of the most common and lethal type of intracranial tumor which is glioblastoma, were exposed to these nanoparticles, demonstrating their efficient uptake. It was showed that MPEG-PCL nanoparticles containing WSE offered better protection to U251 cells against tert-butyl hydroperoxide (tBHP)-induced oxidative damage (95.1%), compared to PCL nanoparticles with WSE (56.4%) and free WSE (39.0%). In vivo distribution of these nanoparticles was further analyzed using zebrafish embryos to validate their biocompatibility in a relevant vertebrate neurodevelopment model.</p> Gregory Marslin, Bruno Filipe Carmelino Sarmento, Joana Filipa Ribeiro Fernandes, Pedro Filipe Ferreira de Sousa Moreira, Olga Maria Fernandes Pereira Coutinho, Marisa Sárria Pereira de Passos, Alberto Carlos Pires Dias, Andreia Ferreira de Castro Gomes Copyright (c) 2024 Gregory Marslin, Bruno Filipe Carmelino Sarmento, Joana Filipa Ribeiro Fernandes, Pedro Filipe Ferreira de Sousa Moreira, Olga Maria Fernandes Pereira Coutinho, Marisa Sárria Pereira de Passos, Alberto Carlos Pires Dias, Andreia Ferreira de Castro Gomes https://creativecommons.org/licenses/by/4.0 https://revistas.uminho.pt/index.php/jus/article/view/5628 Fri, 18 Oct 2024 00:00:00 +0000 Breaking Boundaries in Malaria Research: Design of a Genetic Tool for High-Throughput Gametocidal Drug Screening https://revistas.uminho.pt/index.php/jus/article/view/5702 <p>Malaria, a devastating illness remains a global health concern with an estimated 249 million malaria cases in 85 malaria-endemic countries around the world. Malaria elimination, challenged by drug resistance, requires strategic interventions that could be the implementation of antimalarials with selective actions on the different phases of the parasite life cycle. Of particular relevance is gametocytocidal drugs that could be used to prevent transmission of malaria infection to the mosquito.</p> <p>Finding drugs with gametocidal effect thus are limited by the technical challenges of large-scale production and quantification of parasite transmission stage, gametocytes. To surmount these obstacles, our study endeavors to design a genetic engineering strategy (a vector construct) to further deliver nucleic acid information through transfections-based systems in the form of a plasmid into Plasmodium falciparum. This approach will enable us to engineer a transgenic parasite line for multi-stage drug screening, targeting the symptomatic intra-erythrocyte parasite stage and gametocytes.</p> <p>Genetic engineering tools such as selected linked integration system and attB-attP site-specific recombination will be used in our vector construct aiming the genetic integration process into the P. falciparum genome. These systems will accommodate strategies for easy and accurate stage-specific quantification such as RFP-luciferase fusion cloned downstream stage-specific promoters leading to reporter products with optical outputs and for efficient production of gametocytes at large scale using a riboswitch-based inducible gene expression system. Such technology is of major need and will pave the way for scaling up the capacity for high-throughput drug screening, leading to improved strategies to find drugs capable of blocking malaria transmission.</p> Beatriz Velosa da Fonseca, Maria Isabel Mendes Veiga, Vitória Baptista, Leyre Pernaute-Lau, Nuno Osório, Carla Calçada Copyright (c) 2024 Beatriz Velosa da Fonseca https://creativecommons.org/licenses/by/4.0 https://revistas.uminho.pt/index.php/jus/article/view/5702 Wed, 17 Apr 2024 00:00:00 +0000